# Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

> **NCT02742909** · PHASE4 · COMPLETED · sponsor: **LI ZHAO** · enrollment: 9 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** rhBNP
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02742909
- **Lead sponsor:** LI ZHAO
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742909, "Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02742909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*